Loss of Receptor for Advanced Glycation End Products (RAGE) Defense: A cause of Charcot neuroarthropathy? Witzke KA, Vinik AI, Grant LM, Grant WP, Parson HK, Pittenger GL, Burcus N Diabetes Care. 2011 May 18; Quote: OBJECTIVE This study investigated the relationship between circulating soluble receptor for advanced glycation end products (sRAGE) and parameters of bone health in patients with Charcot neuroarthropathy (CNA)
More:
Loss of Receptor for Advanced Glycation End Products (RAGE) Defense: A cause of Charcot…
